Table 1. Ratios of median relative expression between different stages of melanoma progression.

	ILT3	ILT4	FOXp3	TGFβ1	TGFβ2	IDO	IL-10
Negative SLN/skin	1.37	0.54	1.74	2.37	0.18	4.02	1.01
Positive SLN/negative SLN	4.00	2.84	4.29	0.97	2.90	3.46	2.00
LN+mel/positive SLN	0.20	0.16	0.07	0.55	0.74	0.12	0.20
LN+mel/skin	1.11	0.25	0.53	1.27	0.38	1.63	0.41

Abbreviations: IDO, indoleamine 2,3-dioxygenase; IL-10, interleukin 10; ILT3, immunoglobulin-like transcript 3; ILT4, immunoglobulin-like transcript 4; LN, lymph node; mel, melanoma; SLN, sentinel lymph nodes; TGFβ, transforming growth factor β.